Alimera Sciences RSI
What is the RSI of Alimera Sciences?
The RSI of Alimera Sciences Inc. is 55.60
What is the definition of RSI?
The relative strength index (RSI 14) is a momentum indicator that compares the magnitude of gains and losses over a specified time period to measure speed and change of price movements of a security.
14-day period
It is used to identify overbought or oversold conditions in the trading of an asset. It oscillates between 0 and 100 and a stock is considered overbought when the RSI is above 70 and oversold when below 30. The relative strength index (RSI) is typically used on a 14-day timeframe and is calculated according to the formula 100 - [ 100 / (1 + RS)] where RS is the ratio of average gain to average loss. In the calculation of average gain and loss for a certain period, taking the prior value plus the current value is a smoothing technique similar to that used in calculating an exponential moving average. This also means that RSI values become more accurate as the calculation period extends.
Sudden large price movements can create false buy or sell signals in the RSI. The RSI is often used in conjunction with trend lines, as trend line support or resistance often coincides with support or resistance levels in the RSI reading. Watching for divergence between price and the RSI indicator is another means of refining its application. Divergence occurs when a security makes a new high or low in price but the RSI does not make a corresponding new high or low value. Bearish divergence, when price makes a new high but the RSI does not is taken as a sell signal. Bullish divergence that is interpreted as a buy signal occurs when price makes a new low, but the RSI value does not.
RSI of companies in the Health Care sector on NASDAQ compared to Alimera Sciences
What does Alimera Sciences do?
alimera, founded in june 2003, is a pharmaceutical company that specializes in the research, development and commercialization of prescription ophthalmic pharmaceuticals. alimera is presently focused on diseases affecting the back of the eye, or retina, because these diseases are not well treated with current therapies and will affect millions of people in aging populations. alimera's commitment to retina specialists and their patients is manifest in its product and in its development portfolio designed to treat early- and late-stage diseases. for more information, please visit www.alimerasciences.com. alimera's european operations are conducted from london by its subsidiary, alimera sciences limited.
Companies with rsi similar to Alimera Sciences
- Maxcyte Inc Com Stk Usd0.01 (Di has RSI of 55.58
- Maiden North America has RSI of 55.58
- Deceuninck NV has RSI of 55.58
- Keli Sensing Technology (Ningbo) Co has RSI of 55.58
- General American Investors Co has RSI of 55.59
- Ishares India U has RSI of 55.59
- Alimera Sciences has RSI of 55.60
- SS&C Technologies Inc has RSI of 55.61
- Envision Solar International has RSI of 55.61
- Cellectis has RSI of 55.61
- Hecla Mining Co has RSI of 55.61
- Goldsource Mines has RSI of 55.61
- Metal Hawk has RSI of 55.61